Style de citation APA (7e éd.)

Adhikari, H., Kattan, W. E., Kumar, S., Zhou, P., Hancock, J. F., & Counter, C. M. (2021). Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity. Nature Portfolio.

Style de citation Chicago (17e éd.)

Adhikari, Hema, Walaa E. Kattan, Shivesh Kumar, Pei Zhou, John F. Hancock, et Christopher M. Counter. Oncogenic KRAS Is Dependent upon an EFR3A-PI4KA Signaling Axis for Potent Tumorigenic Activity. Nature Portfolio, 2021.

Style de citation MLA (8e éd.)

Adhikari, Hema, et al. Oncogenic KRAS Is Dependent upon an EFR3A-PI4KA Signaling Axis for Potent Tumorigenic Activity. Nature Portfolio, 2021.